Page last updated: 2024-10-31

nafoxidine and Cataract

nafoxidine has been researched along with Cataract in 1 studies

Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment."7.65Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. ( Bloom, HJ; Boesen, E, 1974)
"The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment."3.65Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. ( Bloom, HJ; Boesen, E, 1974)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloom, HJ1
Boesen, E1

Other Studies

1 other study available for nafoxidine and Cataract

ArticleYear
Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.
    British medical journal, 1974, Apr-06, Volume: 2, Issue:5909

    Topics: Adult; Aged; Breast Neoplasms; Cataract; Estrogen Antagonists; Female; Humans; Hypophysectomy; Menop

1974